Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10-Year Fabry Outcome Survey (FOS) Analysis
DRUG DESIGN DEVELOPMENT AND THERAPY. Bd. 13. 2019 S. 3705-3715
Erscheinungsjahr: 2019
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Ramaswami, Uma (Autor)
Beck, Michael (Autor)
Hughes, Derralynn (Autor)
Kampmann, Christoph (Autor)
Botha, Jaco (Autor)
Pintos-Morell, Guillem (Autor)
West, Michael L. (Autor)
Niu, Dau-Ming (Autor)
Nicholls, Kathy (Autor)
Giugliani, Roberto (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
